Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Adv ; 5(7): eaaw9535, 2019 07.
Article in English | MEDLINE | ID: mdl-31309159

ABSTRACT

Crimean-Congo hemorrhagic fever virus (CCHFV) is an important human pathogen. Limited evidence suggests that antibodies can protect humans against lethal CCHFV disease but the protective efficacy of antibodies has never been evaluated in adult animal models. Here, we used adult mice to investigate the protection provided against CCHFV infection by glycoprotein-targeting neutralizing and non-neutralizing monoclonal antibodies (mAbs). We identified a single non-neutralizing antibody (mAb-13G8) that protected adult type I interferon-deficient mice >90% when treatment was initiated before virus exposure and >60% when administered after virus exposure. Neutralizing antibodies known to protect neonatal mice from lethal CCHFV infection failed to confer protection regardless of immunoglobulin G subclass. The target of mAb-13G8 was identified as GP38, one of multiple proteolytically cleaved glycoproteins derived from the CCHFV glycoprotein precursor polyprotein. This study reveals GP38 as an important antibody target for limiting CCHFV pathogenesis and lays the foundation to develop immunotherapeutics against CCHFV in humans.


Subject(s)
Antibodies, Monoclonal, Murine-Derived , Antibodies, Neutralizing , Antibodies, Viral , Hemorrhagic Fever Virus, Crimean-Congo/immunology , Hemorrhagic Fever, Crimean , Viral Proteins/immunology , Animals , Antibodies, Monoclonal, Murine-Derived/immunology , Antibodies, Monoclonal, Murine-Derived/pharmacology , Antibodies, Neutralizing/immunology , Antibodies, Neutralizing/pharmacology , Antibodies, Viral/immunology , Antibodies, Viral/pharmacology , Hemorrhagic Fever, Crimean/immunology , Hemorrhagic Fever, Crimean/prevention & control , Mice , Mice, Knockout
2.
Int J Mol Sci ; 20(8)2019 Apr 13.
Article in English | MEDLINE | ID: mdl-31013925

ABSTRACT

The etiology of Kawasaki disease (KD), the leading cause of acquired heart disease in children, is currently unknown. Epidemiology supports a relationship of KD to an infectious disease. Several pathological mechanisms are being considered, including a superantigen response, direct invasion by an infectious etiology or an autoimmune phenomenon. Treating affected patients with intravenous immunoglobulin is effective at reducing the rates of coronary aneurysms. However, the role of B cells and antibodies in KD pathogenesis remains unclear. Murine models are not clear on the role for B cells and antibodies in pathogenesis. Studies on rare aneurysm specimens reveal plasma cell infiltrates. Antibodies generated from these aneurysmal plasma cell infiltrates showed cross-reaction to intracellular inclusions in the bronchial epithelium of a number of pathologic specimens from children with KD. These antibodies have not defined an etiology. Notably, a number of autoantibody responses have been reported in children with KD. Recent studies show acute B cell responses are similar in children with KD compared to children with infections, lending further support of an infectious disease cause of KD. Here, we will review and discuss the inconsistencies in the literature in relation to B cell responses, specific antibodies, and a potential role for humoral immunity in KD pathogenesis or diagnosis.


Subject(s)
Antibodies/immunology , B-Lymphocytes/immunology , Mucocutaneous Lymph Node Syndrome/etiology , Animals , Antibody Formation/immunology , Autoantibodies/immunology , Autoimmunity , B-Lymphocytes/metabolism , Disease Models, Animal , Disease Susceptibility , Humans , Immunity, Humoral , Lymphocyte Activation/immunology , Mucocutaneous Lymph Node Syndrome/diagnosis , Mucocutaneous Lymph Node Syndrome/epidemiology , Mucocutaneous Lymph Node Syndrome/metabolism
3.
J Virol ; 92(21)2018 11 01.
Article in English | MEDLINE | ID: mdl-30111561

ABSTRACT

Crimean-Congo hemorrhagic fever virus (CCHFV) can cause severe hepatic injury in humans. However, the mechanism(s) causing this damage is poorly characterized. CCHFV produces an acute disease, including liver damage, in mice lacking type I interferon (IFN-I) signaling due to either STAT-1 gene deletion or disruption of the IFN-I receptor 1 gene. Here, we explored CCHFV-induced liver pathogenesis in mice using an antibody to disrupt IFN-I signaling. When IFN-I blockade was induced within 24 h postexposure to CCHFV, mice developed severe disease with greater than 95% mortality by 6 days postexposure. In addition, we observed increased proinflammatory cytokines, chemoattractants, and liver enzymes in these mice. Extensive liver damage was evident by 4 days postexposure and was characterized by hepatocyte necrosis and the loss of CLEC4F-positive Kupffer cells. Similar experiments in CCHFV-exposed NOD-SCID-γ (NSG), Rag2-deficient, and perforin-deficient mice also demonstrated liver injury, suggesting that cytotoxic immune cells are dispensable for hepatic damage. Some apoptotic liver cells contained viral RNA, while other apoptotic liver cells were negative, suggesting that cell death occurred by both intrinsic and extrinsic mechanisms. Protein and transcriptional analysis of livers revealed that activation of tumor necrosis factor superfamily members occurred by day 4 postexposure, implicating these molecules as factors in liver cell death. These data provide insights into CCHFV-induced hepatic injury and demonstrate the utility of antibody-mediated IFN-I blockade in the study of CCHFV pathogenesis in mice.IMPORTANCE CCHFV is an important human pathogen that is both endemic and emerging throughout Asia, Africa, and Europe. A common feature of acute disease is liver injury ranging from mild to fulminant hepatic failure. The processes through which CCHFV induces severe liver injury are unclear, mostly due to the limitations of existing small-animal systems. The only small-animal model in which CCHFV consistently produces severe liver damage is mice lacking IFN-I signaling. In this study, we used antibody-mediated blockade of IFN-I signaling in mice to study CCHFV liver pathogenesis in various transgenic mouse systems. We found that liver injury did not depend on cytotoxic immune cells and observed extensive activation of death receptor signaling pathways in the liver during acute disease. Furthermore, acute CCHFV infection resulted in a nearly complete loss of Kupffer cells. Our model system provides insight into both the molecular and the cellular features of CCHFV hepatic injury.


Subject(s)
Hemorrhagic Fever Virus, Crimean-Congo/pathogenicity , Hemorrhagic Fever, Crimean/pathology , Hepatocytes/pathology , Interferon Type I/antagonists & inhibitors , Kupffer Cells/cytology , Liver Failure, Acute/pathology , Liver/pathology , Animals , Antibodies, Blocking/immunology , Cell Line , Chlorocebus aethiops , Cytokines/blood , Disease Models, Animal , Hepatocytes/virology , Humans , Interferon Type I/immunology , Kupffer Cells/virology , Liver/injuries , Liver/virology , Liver Failure, Acute/virology , Mice , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, Knockout , Mice, SCID , Vero Cells
4.
Methods Mol Biol ; 1604: 201-207, 2018.
Article in English | MEDLINE | ID: mdl-28986835

ABSTRACT

Many hemorrhagic fever viruses require BSL-3 or BSL-4 laboratory containment for study. The necessary safety precautions associated with this work often contribute to longer assay times and lengthy decontamination procedures. Here we will discuss recent advances in RNA fluorescence in situ hybridization (FISH) that not only allow entirely new investigations into the replication of these viruses but also demonstrate how this method can be applied to any virus with a known sequence and how it can be rapidly performed to minimize time spent in high containment. We have adapted existing protocols for mRNA detection with appropriate changes for examining viruses in a variety of containment laboratories (Shaffer et al., PLoS One 8:e75120, 2013; Raj et al., Nat Methods 5:877-879, 2008).


Subject(s)
Hantaan virus/genetics , Animals , Humans , In Situ Hybridization, Fluorescence , RNA, Messenger/genetics , RNA, Viral/genetics , Virus Replication/genetics , Virus Replication/physiology
5.
Cell Host Microbe ; 20(3): 357-367, 2016 Sep 14.
Article in English | MEDLINE | ID: mdl-27569558

ABSTRACT

RNA viruses exhibit a variety of genome organization strategies, including multicomponent genomes in which each segment is packaged separately. Although multicomponent genomes are common among viruses infecting plants and fungi, their prevalence among those infecting animals remains unclear. We characterize a multicomponent RNA virus isolated from mosquitoes, designated Guaico Culex virus (GCXV). GCXV belongs to a diverse clade of segmented viruses (Jingmenvirus) related to the prototypically unsegmented Flaviviridae. The GCXV genome comprises five segments, each of which appears to be separately packaged. The smallest segment is not required for replication, and its presence is variable in natural infections. We also describe a variant of Jingmen tick virus, another Jingmenvirus, sequenced from a Ugandan red colobus monkey, thus expanding the host range of this segmented and likely multicomponent virus group. Collectively, this study provides evidence for the existence of multicomponent animal viruses and their potential relevance for animal and human health.


Subject(s)
Colobus/virology , Culicidae/virology , RNA Viruses/isolation & purification , RNA Viruses/ultrastructure , Viruses/isolation & purification , Viruses/ultrastructure , Animals , Microscopy, Fluorescence , Phylogeny , RNA Viruses/classification , RNA Viruses/genetics , Viruses/classification , Viruses/genetics
6.
Virology ; 413(1): 103-10, 2011 Apr 25.
Article in English | MEDLINE | ID: mdl-21377708

ABSTRACT

We performed experiments to determine the effect of PKR activation on respiratory syncytial virus (RSV) replication. We first determined that RSV infection activates PKR which induces the phosphorylation of eIF2α, resulting in the formation of host stress granules. We used RNA interference to decrease endogenous PKR levels. RSV replication was not altered in cells deficient for PKR expression. However, RSV-mediated stress granule formation was significantly reduced in PKR-knockdown cells. As an alternative method to block PKR activation, we used treatment with the kinase inhibitor 2-aminopurine (2-AP). We observed that 2-AP treatment significantly reduced viral replication. We also treated PKR-knockdown cells with 2-AP and inoculated with RSV. Under these conditions, 2-AP treatment diminished viral replication in the absence of PKR expression. These results suggest that PKR activation has a minimal effect on RSV replication and that the antiviral effect of 2-AP during RSV infection likely occurs via a PKR-independent mechanism.


Subject(s)
Cytoplasmic Granules/metabolism , Respiratory Syncytial Virus Infections/enzymology , Respiratory Syncytial Viruses/physiology , Virus Replication , eIF-2 Kinase/metabolism , Cell Line , Cytoplasmic Granules/genetics , Enzyme Activation , Humans , Respiratory Syncytial Virus Infections/genetics , Respiratory Syncytial Virus Infections/metabolism , Respiratory Syncytial Viruses/genetics , eIF-2 Kinase/genetics
7.
J Virol ; 84(23): 12274-84, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20844027

ABSTRACT

Mammalian cell cytoplasmic RNA stress granules are induced during various conditions of stress and are strongly associated with regulation of host mRNA translation. Several viruses induce stress granules during the course of infection, but the exact function of these structures during virus replication is not well understood. In this study, we showed that respiratory syncytial virus (RSV) induced host stress granules in epithelial cells during the course of infection. We also showed that stress granules are distinct from cytoplasmic viral inclusion bodies and that the RNA binding protein HuR, normally found in stress granules, also localized to viral inclusion bodies during infection. Interestingly, we demonstrated that infected cells containing stress granules also contained more RSV protein than infected cells that did not form inclusion bodies. To address the role of stress granule formation in RSV infection, we generated a stable epithelial cell line with reduced expression of the Ras-GAP SH3 domain-binding protein (G3BP) that displayed an inhibited stress granule response. Surprisingly, RSV replication was impaired in these cells compared to its replication in cells with intact G3BP expression. In contrast, knockdown of HuR by RNA interference did not affect stress granule formation or RSV replication. Finally, using RNA probes specific for RSV genomic RNA, we found that viral RNA predominantly localized to viral inclusion bodies but a small percentage also interacted with stress granules during infection. These results suggest that RSV induces a host stress granule response and preferentially replicates in host cells that have committed to a stress response.


Subject(s)
Cytoplasmic Granules/metabolism , Epithelial Cells/metabolism , RNA, Messenger/metabolism , Respiratory Syncytial Virus Infections/metabolism , Respiratory Syncytial Viruses/physiology , Stress, Physiological/physiology , Virus Replication/physiology , Antigens, Surface/metabolism , Blotting, Western , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Line , DNA Helicases , ELAV Proteins , ELAV-Like Protein 1 , Humans , Poly-ADP-Ribose Binding Proteins , RNA Helicases , RNA Interference , RNA Recognition Motif Proteins , RNA-Binding Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction
8.
Nat Methods ; 6(5): 347-9, 2009 May.
Article in English | MEDLINE | ID: mdl-19349979

ABSTRACT

To visualize native or non-engineered RNA in live cells with single-molecule sensitivity, we developed multiply labeled tetravalent RNA imaging probes (MTRIPs). When delivered with streptolysin O into living human epithelial cancer cells and primary chicken fibroblasts, MTRIPs allowed the accurate imaging of native mRNAs and a non-engineered viral RNA, of RNA co-localization with known RNA-binding proteins, and of RNA dynamics and interactions with stress granules.


Subject(s)
Molecular Probe Techniques , RNA/analysis , Actin-Related Protein 2/genetics , Actins/genetics , Animals , Avian Proteins/genetics , Bacterial Proteins/pharmacology , Biotin/chemistry , Carbocyanines/chemistry , Cell Line, Tumor , Cell Membrane Permeability/drug effects , Cell Survival , Cells, Cultured , Chick Embryo , DNA-Binding Proteins/genetics , Fibroblasts/metabolism , Fluorescent Dyes/analysis , Humans , Image Processing, Computer-Assisted , Microscopy, Confocal , Microscopy, Fluorescence , Oligonucleotide Probes/analysis , Oligonucleotide Probes/chemistry , Poly(A)-Binding Proteins/metabolism , RNA/metabolism , RNA, Messenger/analysis , RNA, Messenger/metabolism , RNA-Binding Proteins/genetics , Respiratory Syncytial Virus, Human/genetics , Streptavidin/chemistry , Streptolysins/pharmacology , T-Cell Intracellular Antigen-1
9.
Proc Natl Acad Sci U S A ; 105(29): 10209-14, 2008 Jul 22.
Article in English | MEDLINE | ID: mdl-18621683

ABSTRACT

Respiratory syncytial virus (RSV) infects polarized epithelia, which have tightly regulated trafficking because of the separation and maintenance of the apical and basolateral membranes. Previously we established a link between the apical recycling endosome (ARE) and the assembly of RSV. The current studies tested the role of a major ARE-associated protein, Rab11 family interacting protein 2 (FIP2) in the virus life cycle. A dominant-negative form of FIP2 lacking its N-terminal C2 domain reduced the supernatant-associated RSV titer 1,000-fold and also caused the cell-associated virus titer to increase. These data suggested that the FIP2 C2 mutant caused a failure at the final budding step in the virus life cycle. Additionally, truncation of the Rab-binding domain from FIP2 caused its accumulation into mature filamentous virions. RSV budding was independent of the ESCRT machinery, the only well-defined budding mechanism for enveloped RNA viruses. Therefore, RSV uses a virus budding mechanism that is controlled by FIP2.


Subject(s)
Carrier Proteins/physiology , Membrane Proteins/physiology , Respiratory Syncytial Virus, Human/growth & development , Respiratory Syncytial Virus, Human/physiology , ATPases Associated with Diverse Cellular Activities , Adenosine Triphosphatases/genetics , Adenosine Triphosphatases/physiology , Animals , Carrier Proteins/genetics , Cell Line , Dogs , Endosomal Sorting Complexes Required for Transport , Endosomes/physiology , Endosomes/virology , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Host-Pathogen Interactions , Humans , Membrane Proteins/genetics , Mutation , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Respiratory Syncytial Virus, Human/genetics , Respiratory Syncytial Virus, Human/pathogenicity , Transfection , Vacuolar Proton-Translocating ATPases , Vesicular Transport Proteins/genetics , Vesicular Transport Proteins/physiology , Viral Matrix Proteins/genetics , Viral Matrix Proteins/physiology , Virus Assembly , Virus Shedding , rab GTP-Binding Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...